Long-Term Clinical Course after Successful Initial Treatment in Patients with Mild Erosive Esophagitis: A Prospective Follow-Up Study

医学 食管炎 优势比 维持疗法 外科 置信区间 前瞻性队列研究 内科学 胃肠病学 化疗 回流 疾病
作者
Hideharu Okanobu,Tomohiko Kohno,Kazuki Boda,Hidenori Ochi,Yoshinari Furukawa
出处
期刊:Digestion [Karger Publishers]
卷期号:104 (4): 283-290 被引量:1
标识
DOI:10.1159/000528690
摘要

This study aimed to investigate the clinical course of patients with healed mild erosive esophagitis and clarify the predictive factors for continuous treatment.Fifty-one patients with mild erosive esophagitis who confirmed mucosal healing by endoscopy after initial treatment with vonoprazan (VPZ) were enrolled. The patients continued subsequent treatment of their choice: maintenance therapy with VPZ 10 mg (n = 15), on-demand therapy with VPZ 20 mg (n = 19), or no medication (n = 17). Each patient was prospectively followed up for over 2 years, and the treatment was switched to other options appropriately according to their symptoms.During the mean follow-up period of 3.1 years (range: 2.0-3.9 years), 2 patients who chose maintenance therapy switched to on-demand therapy. One patient who chose on-demand therapy switched to maintenance therapy, while 3 patients switched to no medication. Recurrence of symptoms occurred in 9 patients who chose no medication. They were administered maintenance therapy and five of them were subsequently switched to on-demand therapy. Ultimately, the proportion of patients receiving each treatment was 35.3% (18/51) for maintenance therapy, 43.1% (22/51) for on-demand therapy, and 21.6% (11/51) for no medication. A predictive factor for the need for continuous treatment was the presence of esophageal hiatal hernia (odds ratio: 6.03, 95% confidence interval: 1.43-25.3, p = 0.014).Among patients with healed mild erosive esophagitis, 78.4% required continuous treatment with VPZ, while 21.6% remained symptom free with no medication. On-demand therapy was the most common treatment, and continuous treatment may be recommended for patients with esophageal hiatal hernia.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
lzw123456完成签到,获得积分10
刚刚
量子星尘发布了新的文献求助10
1秒前
1秒前
kcmat完成签到,获得积分20
1秒前
Iridesent0v0完成签到,获得积分10
2秒前
威威完成签到,获得积分10
3秒前
酷波er应助lh采纳,获得10
4秒前
小郑发布了新的文献求助10
4秒前
clock完成签到 ,获得积分10
4秒前
66完成签到,获得积分10
5秒前
Orange应助jinkk采纳,获得10
5秒前
RuiLi完成签到,获得积分10
5秒前
煎饼狗子关注了科研通微信公众号
5秒前
xxxxxb完成签到,获得积分10
5秒前
英姑应助糖糖采纳,获得10
5秒前
淡淡小土豆完成签到 ,获得积分10
6秒前
伶俐的高烽完成签到 ,获得积分10
7秒前
candy6663339完成签到,获得积分10
7秒前
7秒前
gao完成签到 ,获得积分0
8秒前
打打应助科研通管家采纳,获得10
8秒前
完美世界应助科研通管家采纳,获得10
8秒前
科研通AI2S应助科研通管家采纳,获得30
8秒前
英姑应助科研通管家采纳,获得10
8秒前
Akim应助科研通管家采纳,获得20
8秒前
sota完成签到,获得积分10
8秒前
无花果应助科研通管家采纳,获得10
8秒前
8秒前
8秒前
Ava应助科研通管家采纳,获得10
8秒前
爆米花应助科研通管家采纳,获得10
9秒前
SciGPT应助科研通管家采纳,获得10
9秒前
9秒前
田様应助科研通管家采纳,获得10
9秒前
9秒前
9秒前
9秒前
9秒前
9秒前
9秒前
高分求助中
【提示信息,请勿应助】关于scihub 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
徐淮辽南地区新元古代叠层石及生物地层 3000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Handbook of Industrial Diamonds第二卷 1200
Global Eyelash Assessment scale (GEA) 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 550
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4038657
求助须知:如何正确求助?哪些是违规求助? 3576306
关于积分的说明 11375198
捐赠科研通 3306108
什么是DOI,文献DOI怎么找? 1819379
邀请新用户注册赠送积分活动 892698
科研通“疑难数据库(出版商)”最低求助积分说明 815066